[1]
M. Blanco Paniagua and R. Martínez Gutiérrez, “Update of the therapeutics of Inflammatory Bowel Disease (IBD). Biological and biosimilar treatments. Second part. ”, TEYS, vol. 3, no. 11, pp. 57-63, Mar. 2022.